Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-14-059543
Filing Date
2014-10-03
Accepted
2014-10-03 17:32:38
Documents
2
Period of Report
2014-09-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v390751_form3.html 3  
1 OWNERSHIP DOCUMENT v390751_form3.xml 3 7415
2 EXHIBIT 24 v390751_ex24.htm EX-24 6129
  Complete submission text file 0001144204-14-059543.txt   14928
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Stellar Biotechnologies, Inc. (Issuer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O STELLAR BIOTECHNOLOGIES, INC. 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address
MORSE DANIEL E. (Reporting) CIK: 0001621331 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54598 | Film No.: 141141071